Home

Presidio Partners 2007 (Parallel), L.P.

CIK 1405972 · last filed 2018-07-26

Presidio Partners 2007 (Parallel), L.P. is a corporate insider who has filed 18 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing, for MNLO, was dated Jul 26, 2018. Across all open-market trades the lifetime net is −$52.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $10.7M across reported positions. The firm reports its address in San Francisco, CA. 48 SEC filings were submitted jointly with Presidio Partners 2007, L.P.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$10.73M

Companies

4

Total Filings

18

Lifetime Open-Market Net

-$52.44M

Filer Profile

Reported Address
655 MONTGOMERY STREET, SUITE 6-161
SAN FRANCISCO, CA 94111
Phone
(415) 613-8023
Formerly Known As
CMEA VENTURES VII (PARALLEL) LP (2014–2015)
CMEA VENTURES VILL (PARALLEL) LP (2007–2007)
Related Filers
Presidio Partners 2007, L.P. — 48 joint filings, latest 2018-07-26
David J Collier — 8 joint filings, latest 2018-07-26
Presidio Partners 2007 GP, L.P. — 8 joint filings, latest 2018-07-26
James F Watson — 8 joint filings, latest 2018-07-26
Presidio Partners 2007 GP, LLC — 4 joint filings, latest 2016-04-20
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
VYNE Therapeutics Inc. (MNLO) Delisted 10%+ Owner 152,062 — — $0 1 2018-07-26
Neos Therapeutics, Inc. (NEOS) Delisted 10%+ Owner 1,664,504 $1.15 $1.91M -$4.15M 1 2016-04-15
ARDX 10%+ Owner 2,839,706 $3.78 $10.73M -$23.86M 3 2015-04-10
Auspex Pharmaceuticals, Inc. (ASPX) Delisted 10%+ Owner 2,541,610 — — -$24.43M 13 2015-04-06

Recent Filings

18 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-07-26 VYNE Therapeutics Inc. (MNLO) Delisted Other (J) +912,372 $0 EDGAR
2016-04-15 Neos Therapeutics, Inc. (NEOS) Delisted Sell (S) −405,776 -$4.15M EDGAR
2015-04-10 ARDX Other (J) −800,000 $0 EDGAR
2015-04-06 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Mixed −600,000 -$17.87M EDGAR
2015-02-26 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Other (J) −400,000 $0 EDGAR
2015-02-17 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Mixed +77,992 -$101 EDGAR
2015-02-11 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Sell (S) −168,308 -$10.28M EDGAR
2015-02-06 Auspex Pharmaceuticals, Inc. (ASPX) Delisted Sell (S) −186,358 -$11.07M EDGAR
2015-02-03 ARDX Sell (S) −340,000 -$9.31M EDGAR
2015-01-12 ARDX Sell (S) −600,000 -$14.55M EDGAR
Showing 1–10 of 18
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.